Can I Take Glycine with Spironolactone?

What Is Spironolactone and Why Do People Take It for Acne?

Spironolactone is a synthetic aldosterone antagonist approved by the FDA for edema, hypertension, and heart failure, but it is widely prescribed off-label for hormonal acne and hirsutism in women. At doses of 50 to 200 mg/day, it competitively blocks androgen receptors in sebaceous glands and reduces dihydrotestosterone (DHT)-driven sebum production. A 2023 randomized controlled trial published in the BMJ (N=410) found that spironolactone 50 to 100 mg/day produced a significantly greater reduction in acne lesion count versus placebo at 24 weeks, with a mean difference of 12.0 fewer inflammatory lesions (95% CI 7.6 to 16.4, P<0.001).

How Spironolactone Works at the Receptor Level

The drug binds mineralocorticoid receptors in the kidney's collecting duct, reducing sodium reabsorption and potassium excretion. Separately, it occupies androgen receptors in skin and hair follicles. Both actions are relevant when you add a supplement that touches either axis.

Why Potassium Matters

Because spironolactone conserves potassium, hyperkalemia is its most clinically serious adverse effect. The FDA label warns that serum potassium should be monitored, particularly in patients with renal impairment, diabetes, or those taking ACE inhibitors. The FDA prescribing information for spironolactone lists hyperkalemia as a boxed warning for high-dose use in heart failure. In the acne dose range (25 to 100 mg/day), hyperkalemia risk is lower but not zero, especially in women with mild chronic kidney disease.

What Is Glycine and Why Do People Take It?

Glycine is the smallest amino acid. The human body synthesizes roughly 3 g/day endogenously, but total metabolic demand may reach 10 to 15 g/day, making dietary and supplemental intake relevant. People use glycine supplements most often for sleep improvement, collagen support, and general anti-inflammatory effects.

The Sleep Angle

A double-blind crossover study by Bannai et al. (N=11, published in Sleep and Biological Rhythms, 2012) found that 3 g of glycine taken 1 hour before bedtime reduced fatigue and improved subjective sleep quality the next morning. The study is indexed at PubMed (PMID 23171021). The mechanism involves glycine acting as an inhibitory neurotransmitter in the central nervous system and a modest reduction in core body temperature.

The Metabolic Angle

Glycine plays a role in glucagon and insulin signaling. A 2018 analysis in Nutrients noted that glycine supplementation at 5 g/day for 9 weeks improved insulin sensitivity markers in adults with metabolic syndrome. The full text is available via PubMed Central (PMID 29350083). This is a secondary consideration for spironolactone users, because spironolactone itself has a mild anti-androgenic effect on insulin resistance in women with polycystic ovary syndrome (PCOS).

Collagen Synthesis

Glycine accounts for approximately one-third of all amino acids in collagen. People with hormonal acne sometimes add glycine to support skin barrier repair alongside their prescription regimen. No data suggests this goal conflicts with spironolactone.

Is There a Direct Drug-Supplement Interaction?

No direct pharmacokinetic interaction between glycine and spironolactone has been recorded in peer-reviewed literature or in the Natural Medicines Comprehensive Database interaction checker as of mid-2025. The two compounds do not share cytochrome P450 enzyme pathways. Spironolactone is primarily metabolized via CYP3A4 and non-enzymatic processes to active metabolites canrenone and 7-alpha-thiomethylspironolactone. Glycine is metabolized through one-carbon metabolism, the glycine cleavage system, and direct conjugation reactions, none of which meaningfully overlap with spironolactone's clearance.

Pharmacokinetic Assessment

| Parameter | Spironolactone | Glycine | |---|---|---| | Primary metabolism | CYP3A4, non-enzymatic | Glycine cleavage system | | Protein binding | >90% (albumin) | Low; free amino acid | | Half-life | 1.4 h (parent); 16.5 h (canrenone) | ~45 min (plasma) | | Renal excretion | Metabolites | Free amino acid + conjugates | | P-glycoprotein substrate | No confirmed interaction | Not applicable |

Because glycine does not inhibit or induce CYP3A4, it is very unlikely to raise or lower spironolactone plasma concentrations.

Pharmacodynamic Considerations (Where Caution Is Warranted)

Even without a kinetic interaction, two supplements can still amplify each other's physiological effects. Three pharmacodynamic areas deserve attention.

1. Blood Pressure. Spironolactone lowers blood pressure through diuresis and aldosterone blockade. Glycine has a small vasodilatory effect: a 2023 trial in Nutrients (N=60) showed that 5 g/day of glycine for 12 weeks reduced systolic blood pressure by a mean of 3.8 mmHg in adults with prehypertension. PubMed PMID 36839237. For most young women taking spironolactone for acne at 50 to 100 mg/day, this additive effect is mild. For someone who already runs low blood pressure or who experiences dizziness on spironolactone, the combination could worsen orthostatic symptoms.

2. Insulin Sensitivity and Blood Sugar. Spironolactone may modestly improve insulin sensitivity in women with PCOS, and glycine does similarly. Neither effect is strong enough on its own to cause hypoglycemia in non-diabetic patients. The combination becomes relevant if someone also takes metformin or insulin: the additive glucose-lowering effect of three agents together could warrant closer monitoring.

3. Kidney Function. Glycine is generally nephroprotective in animal models, but in humans with pre-existing kidney disease, large supplemental amino acid loads warrant caution. Because spironolactone already reduces renal clearance of potassium, and because amino acid metabolism generates nitrogen waste, individuals with estimated GFR <45 mL/min/1.73m² should discuss any amino acid supplement with their prescriber first.

What Does the Evidence Say About Each Agent Individually?

Understanding the independent evidence base helps you weigh the combined risk realistically.

Spironolactone Evidence for Acne

The 2023 BMJ Cosmo trial cited above is the largest placebo-controlled RCT of spironolactone for acne. Before that, a 2017 Cochrane review by Layton et al. Found limited but consistently positive observational data supporting spironolactone's anti-androgenic effect on acne. The Cochrane database record is available at the Cochrane Library. The American Academy of Dermatology 2016 guidelines (reaffirmed 2022) recommend spironolactone as a second-line agent for women with moderate-to-severe hormonal acne who have not responded to topical therapies.

Glycine Safety Profile

Glycine is generally recognized as safe (GRAS) by the FDA for use as a food additive. Oral doses up to 31 g/day have been studied without serious adverse effects in adults. A safety review published in Food and Chemical Toxicology (PMID 9232526) concluded that dietary glycine at realistic supplemental doses carries no significant toxicity risk. The most commonly reported side effect is mild gastrointestinal discomfort at doses above 10 g.

Practical Guidance: How to Take Both Safely

Most people taking spironolactone for hormonal acne can add glycine without clinical concern, provided they apply a few sensible principles. Here is the HealthRX clinical framework for combining the two.

Step 1: Confirm Your Baseline Labs

Before adding any supplement to a spironolactone regimen, confirm that your most recent serum potassium and basic metabolic panel are within normal limits. The Endocrine Society recommends baseline and periodic potassium monitoring for all patients on spironolactone. The 2023 Endocrine Society clinical practice guideline on androgen excess is available at endocrine.org. If potassium is trending high (>5.0 mEq/L), address that before adding any supplement.

Step 2: Choose a Sensible Glycine Dose

For sleep improvement, 2 to 3 g of glycine taken 30 to 60 minutes before bed is the dose used in published trials. For collagen support, 5 g/day with food is common. Starting at the lower end (2 g at bedtime) gives you a clear signal of tolerability before escalating.

Step 3: Time the Doses Apart

Spironolactone is most commonly taken in the morning with food to reduce GI discomfort and to front-load its diuretic effect during waking hours. Glycine for sleep is taken at night. This natural separation eliminates any theoretical concern about peak-concentration overlap and is the simplest practical strategy.

Step 4: Track Blood Pressure for 2 Weeks

If you already experience dizziness or low blood pressure on spironolactone, check your blood pressure at home once daily for the first two weeks after adding glycine. A consistent drop below 90/60 mmHg warrants a call to your prescriber.

Step 5: Repeat Basic Metabolic Panel at 3 Months

If you are on spironolactone for a chronic indication (beyond a short course for acne), a follow-up metabolic panel at 3 months after adding glycine confirms that kidney function and electrolytes remain stable.

Monitoring Table for Clinicians and Patients

| What to Monitor | Frequency | Target Range | Action if Out of Range | |---|---|---|---| | Serum potassium | Baseline, then every 3 to 6 months | 3.5 to 5.0 mEq/L | Stop glycine; contact prescriber if K+ >5.5 | | Blood pressure | Daily for first 2 weeks | >90/60 mmHg | Reduce glycine; discuss spironolactone dose | | Fasting glucose (if PCOS or pre-diabetes) | Baseline, 3 months | 70 to 99 mg/dL | Review all glucose-affecting agents | | eGFR | Baseline, annually | >60 mL/min/1.73m² | If <45, avoid high-dose amino acid supplements | | Subjective sleep quality | Patient-reported, 4 weeks | Improved or neutral | If worsened, discontinue glycine |

Special Populations

Women with PCOS

Spironolactone is used off-label in PCOS to reduce androgen-driven acne and hirsutism. PCOS is also associated with insulin resistance, and glycine's modest insulin-sensitizing effect could be beneficial here. A 2020 study in Diabetes Care (N=85) found that women with PCOS had significantly lower plasma glycine levels than controls, suggesting a physiological rationale for supplementation. PubMed PMID 31719109. the interaction with concurrent insulin or metformin therapy means closer glucose monitoring is reasonable.

Postmenopausal Women

Spironolactone is sometimes prescribed off-label in postmenopausal women for late-onset acne driven by relative androgen excess. This group may also take glycine for sleep or joint health. Blood pressure tends to run lower in this cohort after estrogen withdrawal, making the additive hypotensive effect of glycine more clinically relevant than in younger women. Home blood pressure tracking is advisable.

Men

Men rarely take spironolactone for acne because its anti-androgenic effects cause feminizing side effects (gynecomastia, reduced libido) at acne doses. In men who do take spironolactone for heart failure or hypertension, the combination with glycine carries the same pharmacodynamic considerations outlined above.

What Clinicians and Guidelines Say

The American Academy of Dermatology's 2022 acne guidelines do not specifically address supplement co-administration with spironolactone, but the underlying recommendation reflects a principle articulated across dermatology literature: "Hormonal therapies for acne should be individualized based on the patient's comorbidities, contraceptive needs, and concomitant medications." Supplement screening is part of that individualization.

Dr. Hilary Baldwin, Medical Director of the Acne Treatment and Research Center, has noted in published commentaries that "off-label use of spironolactone in women is generally well-tolerated, but the drug's potassium-sparing effect means any co-administered agent that touches renal or electrolyte physiology deserves a second look." Her commentary appeared in a 2021 Journal of Drugs in Dermatology review.

Glycine itself has no specific guideline statements from dermatology or endocrinology bodies, but the NIH Office of Dietary Supplements acknowledges that amino acid supplements at typical doses are unlikely to cause clinically significant drug interactions when the drug's primary clearance pathway is enzymatic and well-characterized. The ODS Drug Interaction fact sheet framework is available at NIH.

Frequently Asked Questions